Journal of Korean Clinical Nursing Research (임상간호연구)

Hospital Nurses Association (병원간호사회)
권호 표지
DOI QR코드

DOI QR Code

Evidence-Based Clinical Practice Guideline for Fluid Therapy to Prevent Contrast-induced Nephropathy

조영제 유발 신장병증 예방을 위한 수액요법에 관한 근거기반 임상실무지침 개발

  • Lee, Kyung Hae (Division of Nursing, Yonsei University Health System) ;
  • Shin, Kyung Min (Division of Nursing, Yonsei University Health System) ;
  • Lee, Hyeon Jeong (Division of Nursing, Yonsei University Health System) ;
  • Kim, So Young (Division of Nursing, Yonsei University Health System) ;
  • Chae, Jung Won (Division of Nursing, Yonsei University Health System) ;
  • Kim, Mi Ra (Division of Nursing, Yonsei University Health System) ;
  • Han, Min Young (Division of Nursing, Yonsei University Health System) ;
  • Ahn, Mi Sook (Division of Nursing, Yonsei University Health System) ;
  • Park, Jin Kyung (Division of Nursing, Yonsei University Health System) ;
  • Chung, Mi Ae (Division of nursing, Yonsei University Health System) ;
  • Chu, Sang Hui (College of Nursing, Yonsei University) ;
  • Hwang, Jung Hwa (Division of Nursing, Yonsei University Health System)
  • Received : 2016.09.30
  • Accepted : 2017.02.16
  • Published : 2017.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: This study was to develop evidence-based clinical practice guideline in order to prevent contrastinduced nephropathy (CIN) for patients undergoing percutaneous coronary intervention (PCI). Methods: The guideline was developed based on the "Scottish Intercollegiate Guidelines Network (SIGN)". The first draft of guideline was developed through 5 stages and evaluated by 10 experts.(1) Clinical questions were ensured in PICO format.(2) Two researchers conducted a systematic search through electronic database, identifying 170 studies. We selected 27 full text articles including 16 randomized clinical trials, 7 systematic reviews, and 4 guidelines. Quality of each studies were evaluated by the Cochran's Risk of Bias, AMSTAR, K-AGREEII. Among the studies, 11 studies were excluded.(3) The strength of recommendations were classified and quality of recommendations were ranked.(4) Guideline draft was finalized.(5) Content-validation was conducted by an expert group. All contents were ranked above 0.8 in CVI. Results: Evidence-based clinical practice guideline to prevent CIN was dveloped.(1) The guideline for preventing CIN recommends using 0.9% saline.(2) Standardized rate of fluid therapy is 1 to 1.5ml/kg/hr.(3) Execute hydration for 6~12hrs before PCI and after PCI. Conclusion: This study suggests evidence-based clinical practice guideline for preventing CIN which can be more efficiently used in clinical practice.

Keywords

References

  1. Solomon R, Dauerman HL. Contrast-induced acute kidney injury. Circulation. 2010;122(23):2451-2455. http://dx.doi.org/10.1161/CIRCULATIONAHA.110.953851
  2. McCullough PA. Contrast-induced acute kidney injury. Journal of the American College of Cardiology. 2008;51(15):1419-1428. http://dx.doi.org/10.1016/j.jacc.2016.05.099
  3. Koulouridis I, Price LL, Madias NE, Jaber BL. Hospital-acquired acute kidney injury and hospital readmission: a cohort study. American Journal of Kidney Diseases. 2015;65(2):275-282. http://dx.doi.org/10.1053/j.ajkd.2014.08.024
  4. Mitchell AM, Jones AE, Tumlin JA, Kline JA. Incidence of contrast-induced nephropathy after contrast-enhanced computed tomography in the outpatient setting. Clinical Journal of the American Society of Nephrology. 2010;5(1):4-9. http://dx.doi.org/10.2215/CJN.05200709
  5. Nunag M, Brogan M, Garrick R. Mitigating contrast-induced acute kidney injury associated with cardiac catheterization. Cardiology in Review. 2009;17(6):263-269. http://dx.doi.org/10.1097/CRD.0b013e3181bc359d
  6. Kato K, Sato N, Yamamoto T, Iwasaki YK, Tanaka K, Mizuno K. Valuable markers for contrast-induced nephropathy in patients undergoing cardiac catheterization. Circulation Journal. 2008;72(9):1499-1505. https://doi.org/10.1253/circj.CJ-07-1006
  7. Wi J, Ko YG, Kim JS, Kim BK, Choi D, Ha JW, et al. Impact of contrast-induced acute kidney injurywith transient or persistent renal dysfunction on long-term outcomes of patients with acute myocardial infarction undergoing percutaneous coronary intervention. Heart. 2011;97(21):1753-1757. http://dx.doi.org/10.1136/hrt.2010.218677
  8. Wi J, Ko YG, Shin DH, Kim JS, Kim BK, Choi D, et al. Prediction of contrast induced nephropathy with persistent renal dysfunction and adverse long term outcomes in patients with acutemyocardial infarction using theMehran risk score. Clinical Cardiology. 2013;36(1):46-53. https://doi.org/10.1002/clc.22060
  9. Mueller C, Buerkle G, Buettner HJ, Petersen J, Perruchoud AP, Eriksson U, et al. Prevention of contrastmedia-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Archives of Internal Medicine. 2002;162(3):329-336. https://doi.org/10.1001/archinte.162.3.329
  10. Trivedi H, Daram S, Szabo A, Bartorelli AL, Marenzi G. High-dose N-acetylcysteine for the prevention of contrastinduced nephropathy. The American Journal of Medicine. 2009;122(9):874.e9-15. http://dx.doi.org/10.1016/j.amjmed.2009.01.035
  11. Ellis JH, Cohan RH. Prevention of contrast-induced nephropathy: an overview. Radiologic Clinics of North America. 2009;47(5):801-811. http://dx.doi.org/10.1016/j.rcl.2009.06.003
  12. Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, et al. Asimple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. Journal of the American College of Cardiology. 2004;44(7):1393-1399. https://doi.org/10.1016/j.jacc.2004.06.068
  13. Park TN. Development of evidence-based nursing practice guideline for non-phamacologic management of constipation in institutionalized elderly [dissertation]. Daegu: Keimyung University. 2006. p. 1-157.
  14. Scottish Intercollegiate Guidelines Network. SIGN 50: A guideline developer's handbook Quick reference guide [Internet]. NHSScotland: SIGN; 2015[cited 2017 April 11]. Available from: http://www.sign.ac.uk/pdf/qrg50.pdf.
  15. Jo SH, Koo BK, Park JS, Kang HJ, Kim YJ, Kim HL, et al. N-acetylcysteine versus ascorbic acid for preventing contrastinduced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-a prospective randomized controlled trial. American Heart Journal. 2009;157(3):576-583. http://dx.doi.org/10.1016/j.ahj.2008.11.010
  16. Koc F, Ozdemir K, Altunkas F, Celik A, Dogdu O, Karayakali M, et al. Sodiumbicarbonate versus isotonic saline for the prevention of contrast-induced nephropathy in patients with diabetes mellitus undergoing coronary angiography and/or intervention. Journal of Investigative Medicine. 2013;61(5):872-877. https://doi.org/10.2310/JIM.0b013e31828e9cab
  17. Jaffery Z, Verma A,White CJ, Grant AG, Collins TJ, GriseMA, et al. A randomized trial of intravenous N-acetylcysteine to prevent contrast induced nephropathy in acute coronary syndromes. Catheterization andCardiovascular Interventions. 2012;79(6):921-926. https://doi.org/10.1002/ccd.23157
  18. Tamura A, Goto Y, Miyamoto K, Naono S, Kawano Y, Kotoku M, et al. Efficacy of single-bolus administration of sodiumbicarbonate to prevent contrast-induced nephropathy in patients with mild renal insufficiency undergoing an elective coronary procedure. The American Journal of Cardiology. 2009;104(7):921-925. http://dx.doi.org/10.1016/j.amjcard.2009.05.034
  19. ACT Investigators. Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized acetylcysteine for contrast-induced nephropathy trial(ACT). Circulation. 2011;124(11):1250-1259. https://doi.org/10.1161/CIRCULATIONAHA.111.038943
  20. Albabtain MA, Almasood AL, Alshurafah H, Alamri H, Tamim H. Efficacy of ascorbic acid, N-acetylcysteine, or combination of both on top of saline hydration versus saline hydration alone on prevention of contrast induced nephropathy: a prospective randomized study. Journal of Interventional Cardiology. 2013;26(1):90-96. http://dx.doi.org/10.1111/j.1540-8183.2012.00767.x
  21. Vasheghani-Farahani A, Sadigh G, Kassaian SE, Khatami SM, Fotouhi A, Razavi SA, et al. Sodium bicarbonate plus isotonic saline versus saline for prevention of contrast-induced nephropathy in patients undergoing coronary angiography: a randomized controlled trial. American Journal of Kidney Diseases. 2009;54(4):610-618. http://dx.doi.org/10.2310/JIM.0b013e31828e9cab
  22. Sun Z, Fu Q, Cao L, Jin W, Cheng L, Li Z. Intravenous N-acetylcysteine for prevention of contrast-induced nephropathy: a meta-analysis of randomized, controlled trials. PLoS One. 2013;8(1):e55124. http://dx.doi.org/10.1371/journal.pone.0055124
  23. Pannu N, Manns B, Lee H, Tonelli M. Systematic reviewof the impact of N-acetylcysteine on contrast nephropathy. Kidney International. 2004;65(4):1366-1374. https://doi.org/10.1111/j.1523-1755.2004.00516.x
  24. Duong MH, MacKenzie TA, Malenka DJ. N-acetylcysteine prophylaxis significantly reduces the risk of radiocontrastinduced nephropathy: comprehensivemeta-analysis. Catheterization and Cardiovascular Interventions. 2005:64(4):471-479. https://doi.org/10.1002/ccd.20342
  25. Cheungpasitporn W, Thongprayoon C, Brabec BA, Edmonds PJ, O'Corragain OA, Erickson SB. Oral hydration for prevention of contrast-induced acute kidney injury in elective radiological procedures: a systematic review andmeta-analysis of randomized controlled trials. North American Journal of Medical Sciences. 2014;6(12):618-624. http://dx.doi.org/10.4103/1947-2714.147977
  26. Kwok CS, Pang CL, Yeong JK, Loke YK. Measures used to treat contrast-induced nephropathy: overview of reviews. The British Journal of Radiology. 2013;86(1021):20120272. http://dx.doi.org/10.1259/bjr.20120272
  27. Ad-hoc working group of ERBP, Fliser D, Laville M, Covic A, Fouque D, Vanholder R, et al. A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving GlobalOutcomes(KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy. Nephrology Dialysis Transplantation. 2012;27(12):4263-4272. http://dx.doi.org/10.1093/ndt/gfs375
  28. Stacul F, van der Molen AJ, Reimer P, Webb JA, Thomsen HS, Morcos SK, et al. Contrast induced nephropathy: updated ESUR contrast media safety committee guidelines. European Radiology. 2011;21(12):2527-2541. http://dx.doi.org/10.1007/s00330-011-2225-0
  29. Owen RJ, Hiremath S, Myers A, Fraser-Hill M, Barrett BJ. Canadian association of radiologists consensus guidelines for the prevention of contrast-induced nephropathy: update 2012. Canadian Association of Radiologists Journal. 2014;65(2):96-105. http://dx.doi.org/10.1016/j.carj.2012.11.002
  30. OhnoI, Hayashi H, Aonuma K,Horio M, Kashihara N, Okada H, et al. Guidelines on the use of iodinated contrast media in patientswith kidney disease 2012: digest version. Clinical and Experimental Nephrology. 2013;17(4):441-479. http://dx.doi.org/10.1007/s10157-013-0843-3